glp 1 agonist crohn's disease Glucagon-like peptide-1 (GLP-1) receptor agonists in inflammatory bowel disease: mechanisms, clinical implications, and therapeutic potential GLP-1s and Crohn's Disease: Safety,
Description
Formal analysis: Xilong Li

While natural GLP1 levels fluctuate throughout the day, Ozempic provides a consistent therapeutic effect

These drugs offer substantial potential health benefits, but the combination of intense demand, new uses, and high prices for these treatments is likely to place tremendous pressure on Medicare spending, Part D plan costs, and premiums for Part D coverage.

Panagaki T, Gengler S, Hlscher C
